The table below indicates the characteristics of patients in the Intention-To-Treat (ITT) population. Almost 70% of the patients had advanced Hepatocellular Carcinoma (HCC) (Barcelona Clinic Liver Cancer (BCLC) stage C), with portal vein thrombosis and no extrahepatic spread. A significant proportion of the patients had failed Transarterial Chemoembolisation (TACE).
The table below indicates the characteristics for the patients in the per-protocol-population.
Vilgrain V et al. Lancet Oncol 2017; 18: 1624–36.